Reinventing Molecular Imaging with Total-Body PET, Part I: Technical Revolution in Evolution.

Total-body PET (TB-PET) is a technical advancement providing improved signal detection (effective sensitivity). This is achieved through a novel extended detector geometry among many other fine attunements. This technical evolution will ripple through molecular imaging revolutionizing clinical practice beyond the expectations of its designers. This article explores how this leap forward in effective sensitivity through TB-PET could enable dose reduction, faster imaging, temporal resolution improvement, dynamic imaging, and the in vivo noninvasive study of clinical systems biology. TB-PET has the potential to be an enabler of disruptive innovations in molecular imaging. This will change the landscape of medical imaging.

[1]  Martin A Lodge,et al.  Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application , 2013, Physics in medicine and biology.

[2]  A. Alavi,et al.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck , 1999, European Journal of Nuclear Medicine.

[3]  A. Alavi,et al.  Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[4]  Eric Berg,et al.  Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging , 2018, The Journal of Nuclear Medicine.

[5]  V. R. McCready,et al.  FDG accumulation and tumor biology. , 1998, Nuclear medicine and biology.

[6]  Joel S Karp,et al.  Total-body imaging: Transforming the role of positron emission tomography , 2017, Science Translational Medicine.

[7]  Eric Berg,et al.  Mini EXPLORER II: a prototype high-sensitivity PET/CT scanner for companion animal whole body and human brain scanning , 2019, Physics in medicine and biology.

[8]  S. Hess,et al.  An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Abass Alavi,et al.  Guest editorial: the conception of FDG-PET imaging. , 2002, Seminars in nuclear medicine.

[10]  Abass Alavi,et al.  The pivotal role of FDG-PET/CT in modern medicine. , 2014, Academic radiology.

[11]  A. Alavi,et al.  Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Pengcheng Hu,et al.  First Human Imaging Studies with the EXPLORER Total-Body PET Scanner* , 2019, The Journal of Nuclear Medicine.

[13]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  S. Houshmand,et al.  An update on novel quantitative techniques in the context of evolving whole-body PET imaging. , 2015, PET clinics.

[15]  Joel S. Karp,et al.  Development of PET for Total-body Imaging , 2017 .

[16]  Nicolas A Karakatsanis,et al.  Physical Performance of a Long Axial Field of View PET Scanner Prototype with Sparse Rings Configuration: A Monte Carlo Simulation Study. , 2020, Medical physics.

[17]  A. Alavi,et al.  Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  T. Werner,et al.  Dynamic Changes of FDG Uptake and Clearance in Normal Tissues , 2013, Molecular Imaging and Biology.

[20]  W. Segars,et al.  4D XCAT phantom for multimodality imaging research. , 2010, Medical physics.

[21]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[22]  W. Moses,et al.  Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care , 2018, The Journal of Nuclear Medicine.

[23]  Xuezhu Zhang,et al.  Subsecond total-body imaging using ultrasensitive positron emission tomography , 2020, Proceedings of the National Academy of Sciences.

[24]  Joel S Karp,et al.  PennPET Explorer: Human Imaging on a Whole-Body Imager , 2019, The Journal of Nuclear Medicine.

[25]  L. Sokoloff.  [1-14C]-2-deoxy-d-glucose method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the "lumped" constants. , 1976, Neurosciences Research Program bulletin.

[26]  Suleman Surti,et al.  Total Body PET: Why, How, What for? , 2020, IEEE Transactions on Radiation and Plasma Medical Sciences.

[27]  H. Zaidi,et al.  Tracer Kinetic Modeling in PET. , 2007, PET clinics.

[28]  Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies , 2019, The Journal of Nuclear Medicine.

[29]  R. Gibbons,et al.  Weighing the risks and benefits of cardiac imaging with ionizing radiation. , 2010, JACC. Cardiovascular imaging.

[30]  Habib Zaidi,et al.  Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation–maximization reconstruction , 2016, Physics in Medicine and Biology.

[31]  W. Moses,et al.  Corrigendum: Optimal whole-body PET scanner configurations for different volumes of LSO scintillator: a simulation study , 2012, Physics in medicine and biology.

[32]  S. Cherry,et al.  Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection , 2019, The Journal of Nuclear Medicine.

[33]  Jonathan Ka Poon,et al.  The Performance Limits of Long Axial Field of View PET Scanners , 2013 .

[34]  R. Morin,et al.  Image Wisely: The Beginning, Current Status, and Future Opportunities. , 2017, Journal of the American College of Radiology : JACR.

[35]  Chan Hyeong Kim,et al.  Advances in Computational Human Phantoms and Their Applications in Biomedical Engineering—A Topical Review , 2019, IEEE Transactions on Radiation and Plasma Medical Sciences.

[36]  S. Cherry.  The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons)--advances in PET imaging technology. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  F. Hofheinz,et al.  Dual time point based quantification of metabolic uptake rates in 18F-FDG PET , 2013, EJNMMI Research.

[38]  D. Miglioretti,et al.  Rising use of diagnostic medical imaging in a large integrated health system. , 2008, Health affairs.

[39]  Heiko Schöder,et al.  Deep-inspiration breath-hold PET/CT of the thorax. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  M. Reivich,et al.  Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose , 1978 .

[41]  D. Dey,et al.  Three-Hour Delayed Imaging Improves Assessment of Coronary 18F-Sodium Fluoride PET , 2018, The Journal of Nuclear Medicine.